GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jinling Pharmaceutical Co Ltd (SZSE:000919) » Definitions » 3-Year Revenue Growth Rate

Jinling Pharmaceutical Co (SZSE:000919) 3-Year Revenue Growth Rate : 3.60% (As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Jinling Pharmaceutical Co 3-Year Revenue Growth Rate?

Jinling Pharmaceutical Co's Revenue per Share for the three months ended in Mar. 2024 was ¥1.46.

During the past 12 months, Jinling Pharmaceutical Co's average Revenue per Share Growth Rate was 4.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 3.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 0.20% per year. During the past 10 years, the average Revenue per Share Growth Rate was -1.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Jinling Pharmaceutical Co was 33.80% per year. The lowest was -10.90% per year. And the median was 8.00% per year.


Competitive Comparison of Jinling Pharmaceutical Co's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Jinling Pharmaceutical Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jinling Pharmaceutical Co's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jinling Pharmaceutical Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Jinling Pharmaceutical Co's 3-Year Revenue Growth Rate falls into.



Jinling Pharmaceutical Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Jinling Pharmaceutical Co  (SZSE:000919) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Jinling Pharmaceutical Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Jinling Pharmaceutical Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Jinling Pharmaceutical Co (SZSE:000919) Business Description

Traded in Other Exchanges
N/A
Address
No. 238 Zhongyang Road, Jinling Pharmaceutical Building, Nanjing, Jiangsu, CHN, 210009
Jinling Pharmaceutical Co Ltd is a China-based pharmaceutical company.
Executives
Fan Jin Tian Director
Jia Ming Yi Executives
Li Quan Executives
Chen Sheng Executives
Xu Jun Yang Secretary Dong
Wang Yang Executives
Yin Jian Biao Executives
Li Jian Executives
Liang Yu Tang Directors, executives
Zhang Ning Executives
Li Chun Min Director
Sui Li Cheng Executives
Tang Wei Guo Directors, executives
Wang Suo Jin Executives
Shen Zhi Long Director

Jinling Pharmaceutical Co (SZSE:000919) Headlines

No Headlines